Today

Agents

Chat

Arena

Discover

More

App

Nektar grants 36,000 inducement stock options priced at $64.84 per share

NKTR•2026-07-24

Inducement stock option grant

Nektar Therapeutics granted non-qualified stock options covering to on .

36,000 shares

23 newly hired employees

July 20, 2026

The options were issued under the company’s 2025 Inducement Plan, adopted Nov. 6, 2025.
The exercise price was set at $64.84 per share, matching the July 20 closing price.
The options carry an eight-year term.
Vesting runs over four years: 25% after one year, then monthly over the following three years.

Related News

Braemar Hotels declares Q3 Series B preferred dividend of $0.34/share

BHR•2026-07-24

LiqTech gets Nasdaq notice for failing $1 minimum bid price rule

LIQT•2026-07-24

MDxHealth flags Nasdaq notice over US$35 million market value deficiency

2026-07-24

Quantum-Si gets Nasdaq notice after QSI shares stay below $1 for 30 days

QSI•2026-07-24

International Stem Cell files draft information statement for Lifeline Cell Technology sale to ATCC

ISCO•2026-07-24

Nektar grants 36,000 inducement stock options priced at $64.84 per share - NKTR News | Rallies